fbpx

Posts Tagged ‘Genentech Inc.’

Standard Chemotherapy Regimen for Pleural Mesothelioma May Add Bevacizumab

Standard Chemotherapy Regimen for Pleural Mesothelioma May Add Bevacizumab

Malignant pleural mesothelioma may soon be getting a new standard of care. Bevacizumab may be added to the current standard chemotherapy regimen of pemetrexed and cisplatin. According to Dr. Gerald Zalcman, who recently presented a paper at the 2015 American Society of Clinical Oncology (ASCO) annual meeting, bevacizumab offers patients with malignant pleural mesothelioma longer survival rates...

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus Paul & Siegel has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880